Veru Inc (VERU)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$2.44

+0.31 (+14.55%)

Market Cap: $37.60M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

51%(19/37)

Avg Surprise

-11.74%

Streak

4 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$0.20

Range$0.20 - $0.20

1 analysts

Revenue Consensus

Range$0 - $0

3 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.26

Range$-0.33 - $-0.19

2 analysts

EPS RevisionsNo revisions (7d)No revisions (30d)

EPS Estimate DriftChange to current

90d ago$0.00n/a

60d ago$0.00n/a

30d ago$0.00n/a

7d ago$-0.19-36.8%

Current$-0.26

Revenue Consensus

Range$0 - $0

2 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.26	$-0.33 - $-0.19	-	-	2	No revisions (30d)	-
Sep 30, 2026Sep 26EST	-	$0.20	$0.20 - $0.20	-	-	1	-	-
Jun 30, 2026Jun 26 Reported Aug 10, 2026Reported Aug 10	$-0.30	$-0.32	$-0.34 - $-0.30	+6.25%	Beat	2	1 1 30d	+43.4%
Mar 31, 2026Mar 26 Reported May 13, 2026Reported May 13	$-0.13	N/A	-	+53.57%	Beat	2	No revisions (30d)	+78.3%
Dec 31, 2025Dec 25 Reported Feb 11, 2026Reported Feb 11	$-0.26	$-0.47	$-0.63 - $-0.31	+44.68%	Beat	2	No revisions (30d)	+63.4%
Sep 30, 2025Sep 25 Reported Dec 17, 2025Reported Dec 17	$0.09	$-0.06	-	+258.73%	Beat	1	0 1 30d	+273.1%
Jun 30, 2025Jun 25 Reported Aug 12, 2025Reported Aug 12	$-0.53	$-0.50	$-0.50 - $-0.50	-6.00%	Miss	2	No revisions (30d)	+30.3%
Mar 31, 2025Mar 25 Reported May 8, 2025Reported May 8	$-0.60	$-0.50	$-0.50 - $-0.50	-20.00%	Miss	1	No revisions (30d)	+34.1%
Dec 31, 2024Dec 24 Reported Feb 13, 2025Reported Feb 13	$-0.71	$-0.80	$-0.80 - $-0.80	+11.25%	Beat	1	No revisions (30d)	-787.5%
Sep 30, 2024Sep 24 Reported Dec 16, 2024Reported Dec 16	$-0.05	$-0.08	$-0.08 - $-0.08	+35.00%	Beat	1	No revisions (30d)	+96.2%
Jun 30, 2024Jun 24 Reported Aug 8, 2024Reported Aug 8	$-0.76	$-0.60	$-0.61 - $-0.59	-26.67%	Miss	5	No revisions (30d)	+38.7%
Mar 31, 2024Mar 24 Reported Apr 1, 2024Reported Apr 1	$-0.91	$-1.50	$-1.52 - $-1.49	+39.33%	Beat	3	2 0 30d	+78.9%
Dec 31, 2023Dec 23 Reported Feb 14, 2024Reported Feb 14	$-0.08	$-0.10	$-0.15 - $-0.08	+20.00%	Beat	3	No revisions (30d)	+98.3%
Sep 30, 2023Sep 23 Reported Dec 8, 2023Reported Dec 8	$-1.37	$-2.35	$-2.39 - $-2.32	+41.70%	Beat	2	No revisions (30d)	-168.6%
Jun 30, 2023Jun 23 Reported Aug 10, 2023Reported Aug 10	$-1.24	N/A	-	+57.24%	Beat	2	No revisions (30d)	+55.7%
Mar 31, 2023Mar 23 Reported May 11, 2023Reported May 11	$-4.32	$-3.30	$-3.32 - $-3.28	-30.91%	Miss	4	No revisions (30d)	-140.0%
Dec 31, 2022Dec 22 Reported Feb 9, 2023Reported Feb 9	$-4.60	$-3.77	$-3.80 - $-3.73	-22.02%	Miss	3	No revisions (30d)	-475.0%
Sep 30, 2022Sep 22 Reported Dec 5, 2022Reported Dec 5	$-0.51	$-0.30	$-0.34 - $-0.27	-70.00%	Miss	5	No revisions (30d)	-920.0%
Jun 30, 2022Jun 22 Reported Aug 11, 2022Reported Aug 11	$-2.80	$-1.64	$-1.64 - $-1.64	-70.73%	Miss	0	No revisions (30d)	-833.3%
Mar 31, 2022Mar 22 Reported May 12, 2022Reported May 12	$-1.80	$-1.15	$-1.26 - $-1.08	-56.52%	Miss	4	No revisions (30d)	-350.0%
Dec 31, 2021Dec 21 Reported Feb 9, 2022Reported Feb 9	$-0.80	$-0.67	$-0.78 - $-0.61	-19.40%	Miss	4	No revisions (30d)	-300.0%
Sep 30, 2021Sep 21 Reported Dec 2, 2021Reported Dec 2	$-0.05	$-0.09	$-0.13 - $-0.06	+44.44%	Beat	5	2 1 30d	-266.7%
Jun 30, 2021Jun 21 Reported Aug 12, 2021Reported Aug 12	$-0.30	$-0.60	$-0.62 - $-0.59	+50.00%	Beat	5	No revisions (30d)	+40.0%
Mar 31, 2021Mar 21 Reported May 12, 2021Reported May 12	$-0.40	$-0.30	$-0.33 - $-0.28	-33.33%	Miss	5	1 0 30d	-300.0%
Dec 31, 2020Dec 20 Reported Feb 10, 2021Reported Feb 10	$-0.20	$-0.40	$-0.42 - $-0.36	+50.00%	Beat	3	No revisions (30d)	+60.0%
Sep 30, 2020Sep 20 Reported Dec 9, 2020Reported Dec 9	$0.03	$-0.04	$-0.04 - $-0.03	+175.00%	Beat	3	No revisions (30d)	+160.0%
Jun 30, 2020Jun 20 Reported Aug 13, 2020Reported Aug 13	$-0.50	$-0.32	$-0.33 - $-0.31	-56.25%	Miss	3	No revisions (30d)	-25.0%
Mar 31, 2020Mar 20 Reported May 13, 2020Reported May 13	$-0.10	N/A	-	+69.70%	Beat	4	No revisions (30d)	+83.3%
Dec 31, 2019Dec 19 Reported Feb 12, 2020Reported Feb 12	$-0.50	$-0.23	$-0.26 - $-0.21	-117.39%	Miss	3	No revisions (30d)	-66.7%
Sep 30, 2019Sep 19 Reported Dec 12, 2019Reported Dec 12	$-0.05	$-0.05	$-0.06 - $-0.04	+0.00%	Beat	4	No revisions (30d)	+64.3%
Jun 30, 2019Jun 19 Reported Aug 8, 2019Reported Aug 8	$-0.40	$-0.45	$-0.46 - $-0.45	+11.11%	Beat	4	No revisions (30d)	+73.3%
Mar 31, 2019Mar 19 Reported May 15, 2019Reported May 15	$-0.60	$-0.60	$-0.62 - $-0.58	+0.00%	Beat	4	No revisions (30d)	+14.3%
Dec 31, 2018Dec 18 Reported Feb 13, 2019Reported Feb 13	$-0.30	$-0.04	$-0.08 - $0.00	-650.00%	Miss	2	No revisions (30d)	+25.0%
Sep 30, 2018Sep 18 Reported Dec 13, 2018Reported Dec 13	$-0.14	$-0.08	$-0.08 - $-0.08	-75.00%	Miss	0	1 0 30d	+53.3%
Jun 30, 2018Jun 18 Reported Aug 14, 2018Reported Aug 14	$-1.50	$-0.80	$-0.83 - $-0.76	-87.50%	Miss	4	No revisions (30d)	-2400.0%
Mar 31, 2018Mar 18 Reported May 9, 2018Reported May 9	$-0.70	$-0.50	$-0.53 - $-0.47	-40.00%	Miss	2	No revisions (30d)	-1487.3%
Dec 31, 2017Dec 17 Reported Jan 2, 2018Reported Jan 2	$-0.40	$-0.30	$-0.30 - $-0.30	-33.33%	Miss	1	No revisions (30d)	-
Jun 30, 2017Jun 17 Reported Aug 8, 2017Reported Aug 8	$-0.30	N/A	-	+62.50%	Beat	-	-	-
Mar 31, 2017Mar 17 Reported May 9, 2017Reported May 9	$-0.06	$-0.04	-	-50.00%	Miss	-	-	-
Dec 31, 2016Dec 16 Reported Feb 9, 2017Reported Feb 9	$-0.04	N/A	-	N/A	Beat	-	-	-

Dividends

Dividend Metrics

Forward Yield0.00%

Forward Annual Dividend$0.00

No dividend payments in the selected period.

Key Metrics

Valuation
P/E Ratio	-4.07	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-64.50%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	4.42x	Quick Ratio	4.42x
Trading Statistics
Beta	-1.20	Avg Volume	205.38K
52-Week High	$4.46	52-Week Low	$2.05

Technical Indicators Dashboard

Moving Averages

SMA 10$2.40

SMA 20$2.46

SMA 50$2.54

SMA 200$2.50

EMA 10$2.38

EMA 20$2.43

EMA 50$2.49

EMA 200$2.71

MACD

Line: -0.06Signal: -0.04Hist: -0.02

ADX

ADX: 23.2+DI: 23.8-DI: 19.9

Aroon & PSAR

Aroon Up72.0

Aroon Down96.0

PSAR$2.94

Bollinger Bands

Upper Band$2.70

Lower Band$2.22

%B Position1945%(Upper)

Band Width0.46

RSI (14-Day)

Neutral

49.4

Momentum Oscillators

Stoch %K18.8

Stoch %D10.1

Williams %R-48.4

ROC (10d)-3.9%

Momentum-0.10

CCI (20d)-103.6

MFI (14d)25.6

Volatility Measures

ATR (14d)$0.15(6.0%)

StdDev (20d)0.12

Hist Vol70.7%(High)

Volume Flow

VWAP$2.35

OBV99.5M

AD Line36.8B

CMF (20d)-0.324

Volume Metrics

Avg Vol (20d)214.7K

Vol Ratio2.3x(High)

VWMA (20d)$2.44

Pivot Points

R3$2.42

R2$2.36

R1$2.24

Pivot Point$2.18

S1$2.06

S2$2.00

S3$1.88

Advanced Oscillators

TSI-12.67

Ultimate Osc39.5

KST-45.51

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$0	$247,064	$0	$0	$0	$6.66M	$0	$0	$0	$3.86M
Cost of Revenue	$0	$0	$0	$28,573	$0	$0	$0	$3.97M	$0	$0	$0	$2.32M
Gross Profit	$0	$0	$0	$-28,573	$0	$0	$0	$2.69M	$0	$0	$0	$1.54M

Operating Expenses	$7.71M	$7.22M	$5.42M	$-1,166,793	$7.55M	$8.12M	$10.25M	$9.34M	$10.55M	$8.89M	$7.39M	$9.72M
R&D	$4.35M	$3.15M	$1.34M	$2.92M	$3.02M	$3.93M	$5.72M	$3.29M	$4.85M	$2.99M	$1.66M	$3.94M
SG&A	$3.36M	$4.07M	$4.08M	$4.54M	$5.01M	$5.16M	$5.23M	$6.25M	$5.81M	$5.90M	$6.65M	$6.77M
Operating Income	$-7,713,681	$-7,218,968	$-5,424,015	$1.17M	$-7,546,476	$-8,122,232	$-10,248,727	$-9,342,962	$-10,545,481	$-8,888,791	$-7,391,826	$-8,176,134

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$0	$0	$0	$0	$0	$0	$-8,624,778	$0	$0	$0	$0	$207,201
Income Before Tax	$-6,988,350	$-3,092,550	$-5,332,579	$1.30M	$-7,323,101	$-7,852,393	$-1,809,903	$-8,549,400	$-10,340,056	$-8,703,099	$-7,667,383	$-7,574,623
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$557,492

Net Income	$-6,988,350	$-2,741,132	$-5,332,579	$1.45M	$-7,332,820	$-7,901,619	$-8,945,347	$-8,530,623	$-10,968,874	$-10,025,948	$-8,275,981	$-8,132,115

EBITDA	$-6,822,994	$-2,929,784	$-5,172,292	$1.46M	$-7,166,504	$-7,698,113	$-10,170,231	$-8,289,217	$-10,084,347	$-8,637,299	$-7,595,254	$-7,297,238
EBIT	$-6,988,350	$-3,092,550	$-5,332,579	$1.30M	$-7,323,101	$-7,852,393	$-10,434,681	$-8,549,400	$-10,340,056	$-8,703,099	$-7,667,383	$-7,367,422

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about VERU

News

Oppenheimer reiterates Veru stock rating ahead of obesity trial data By Investing.com

Oppenheimer has reiterated an Outperform rating and a $24.00 price target for Veru Inc. (NASDAQ:VERU) ahead of upcoming clinical trial results for its obesity treatment candidate...

Investing.com India•Oct 14, 2026 8:12 AM ET10/14/26•Bullish

Oppenheimer reiterates Veru stock rating ahead of obesity trial data

Oppenheimer has reiterated an Outperform rating and a $24.00 price target for Veru Inc. (NASDAQ:VERU) shares, anticipating positive results from the Phase 2b PLATEAU interim analysis for its obesity treatment candidate...

Investing.com•Oct 14, 2026 7:44 AM ET10/14/26•Bullish

Veru Inc Company Profile & Introduction

This article provides a company profile and introduction for Veru Inc., detailing its business operations within the biopharmaceutical sector. It outlines the company's focus and key areas of development...

Moomoo•Oct 7, 2026 4:56 PM ET10/7/26•Neutral

Veru Initiated at Buy by WestPark Capital

WestPark Capital has initiated coverage on Veru with a "Buy" rating. This news indicates a positive outlook from the analytical firm regarding Veru's stock performance and future prospects. Investors may view this...

Moomoo•Oct 7, 2026 6:42 AM ET10/7/26•Bullish

Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference

Veru Inc. announced that its Chairman, President, and CEO, Mitchell Steiner, M.D., will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on September 9, 2026. The company...

Yahoo! Finance Canada•Sep 2, 2026 4:30 AM ET9/2/26•Somewhat-Bullish

VERU Valuation and Fair Value

P/E: -4.1x
Forward P/E: 117.7x
PEG: 3.6x
P/B: 2.0x

See GNG's fair value

VERU Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -64.5%

VERU Competitors

Company	Ticker
Nephros Inc	NEPH
Harvard Bioscience Inc	HBIO
Cosmos Health Inc.	COSM
Incannex Healthcare Inc.	IXHL
FibroGen Inc	FGEN
Star Equity Holdings Inc	STRR
CVRx Inc	CVRX
Generation Bio Co	GBIO

Sector: Healthcare

VERU Bull Case vs Bear Case

Bull case

VERU beat EPS estimates in 75.0% of its last 8 reported quarters.
VERU grew quarterly revenue 18.3% year over year.

VERU Earnings: Beat Rate and Next Report

Beat rate: 6 of 8 quarters (75.0%)
Average surprise: 47.9%
EPS estimate (fiscal period ending Sep 30, 2026): $0.20

VERU Dividend

Forward yield: 0.0%

Frequently Asked Questions About VERU

Does VERU pay dividends?

Veru Inc (VERU) has a dividend payment track record. See the VERU dividend history page for its current payment status, TTM yield, and recorded payments.

What is VERU's market cap?

Veru Inc (VERU) has a market capitalization of $37.60M with a current stock price of $2.44.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In